Abstract
Osteoporosis is closely associated with lifestyle-related diseases, such as diabetes mellitus, hypertension, and hyperlipidemia. The meta-analysis data reveals that risk of hip fracture is higher in the patients with diabetes mellitus or hypertension compared with those without it. Bone quality more markedly contributes to bone strength in osteoporosis associated with diabetes mellitus than without it. The reduction rate of vertebral fractures by raloxifene in the osteoporotic women with diabetes mellitus is higher than or equal to those without it. Raloxifene more markedly reduces vertebral fractures in the osteoporotic women with high value of serum triglyceride. Raloxifene improves hyperlipidemia in the postmenopausal osteoporotic women and increases the value of serum adiponection in the postmenopausal osteoporotic women without diabetes mellitus.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
